Public misconceptions about FDA-approved drugs

By  

Reactions Weekly, Vol. 1, Iss. 1372, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Pharmacogenomic characterization of US FDA-approved cytotoxic drugs

By Peters Eric J   Motsinger-Reif Alison   Havener Tammy M   Everitt Lorraine   Hardison Nicholas E   Watson Venita G   Wagner Michael   Richards Kristy L   Province Mike A   McLeod Howard L  

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1407-1415

Future Medicine

Access to resources Recommend Favorite

Coverage Policy and Use Beyond the FDA-Approved Label

By McGivney William T.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 2, 2006-02 ,pp. : 99-101

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Commercially Available, FDA-approved Epigenetic Modifiers As Therapeutic Agents in Bacterial Infection

By  

Clinical Anti-Inflammatory & Anti-Allergy Drugs, Vol. 2, Iss. 1, 2015-04 ,pp. : 79-88

Bentham Science Publishers

Access to resources Recommend Favorite

In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens

By  

Current Pharmaceutical Design, Vol. 23, Iss. 14, 2017-05 ,pp. : 2147-2157

Bentham Science Publishers

Access to resources Recommend Favorite